SLC5A2 and diabetic kidney disease: Because the proximal tubular epithelium is the direct site of action of SGLT-2 inhibitors, a simulation of several environmental variables, high glucose, and inflammation, was used to examine the direct effect on this cell type in vitro and possibly simulate conditions in the human nephron during diabetic nephropathy.